Latest Articles
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis - Nature
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis Nature
Published: May 15, 2025, 12:37 a.m.
Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients - Stock Titan
Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients Stock Titan
Published: May 14, 2025, 8:10 p.m.
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer - Healio
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer Healio
Published: May 14, 2025, 8:04 p.m.
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer - OncLive
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer OncLive
Published: May 12, 2025, 12:39 p.m.
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 - openPR.com
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 openPR.com
Published: May 12, 2025, 10:53 a.m.
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature
Published: May 10, 2025, 10:19 a.m.
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer - OncLive
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer OncLive
Published: May 9, 2025, 11:26 p.m.
Endometrial Cancer Phase III Shows Molecular Profiling Personalizes Treatment - Inside Precision Medicine
Endometrial Cancer Phase III Shows Molecular Profiling Personalizes Treatment Inside Precision Medicine
Published: May 7, 2025, 6:12 p.m.
Endometrial Cancer Phase III Shows Molecular Profiling, Personalizes Treatment - Inside Precision Medicine
Endometrial Cancer Phase III Shows Molecular Profiling, Personalizes Treatment Inside Precision Medicine
Published: May 7, 2025, 6:12 p.m.
Molecular profiling key to reduce radiation for women with endometrial cancer: Study - thehawk.in
Molecular profiling key to reduce radiation for women with endometrial cancer: Study thehawk.in
Published: May 7, 2025, 4 p.m.
Link copied to clipboard!